PrEP, Pharmakon, and Ambivalence in the Era of Nordic HIV Prevention
DOI:
https://doi.org/10.7146/kkf.v35i1.133743Nøgleord:
HIV, PrEP, pharmakon, Scandinavia, ambivalenceResumé
Using Derrida's notion of pharmakon (again from Plato), I bring attention to how we can utilize the notion of pharmakon as an analytical framing device for thinking about the entanglements between pharmaceuticals, and historical HIV narratives, and the contemporary landscape of HIV in the Nordic region. This article establishes a disciplinary conjecture by arguing that pharmakon as a framing device might add to our understanding of the at-times polemical discourses around PrEP in Scandinavia and elsewhere, and also to our understanding of PrEP as a 'reluctant object' in the phrasing of Kane Race. I argue, through a theoretical reading, that PrEP as pharmakon has much to offer as a way of framing PrEP, in particular when it comes to trying to unpack some of the ambivalence that has surrounded PrEP as a preventive drug against HIV. By doing so, this article aims to (i) introduce a new theoretical reading of PrEP which so far has not been attended to in the literature, and (ii) by doing so, connect this way of framing PrEP to the Nordic setting in particular and the historical development of HIV histories in the Nordic region.
Referencer
Auerbach, J. D., & Hoppe, T. A. (2015). Beyond “getting drugs into bodies”: social science perspectives on pre‐exposure prophylaxis for HIV. Journal of the International AIDS society, 18, 19983. DOI: https://doi.org/10.7448/IAS.18.4.19983
Belluz, J. (2014). The truvada wars. Bmj, 348 DOI: https://doi.org/10.1136/bmj.g3811
Berlingske. (2017). Hiv-virus kan blive fortid i Danmark med ny behandling. Berlingske. Retrieved from https://www.berlingske.dk/samfund/hiv-virus-kan-blive-fortid-i-danmark-med-ny-behandling
Berkowitz, R., Callen, M., & Dworkin, R. (1983). How to have sex in an epidemic: one approach. News from the front publications.
Betts, D. (2021). Who Gets to Be a# TruvadaWhore: Promiscuity, Race, and Queer Politics. Radical History Review, 2021(140), 157-163. DOI: https://doi.org/10.1215/01636545-8841742
Blumenthal, J., & Haubrich, R. (2014). Risk compensation in PrEP: an old debate emerges yet again. The virtual mentor: VM, 16(11), 909. DOI: https://doi.org/10.1001/virtualmentor.2014.16.11.stas1-1411
Blumenthal, J., & Haubrich, R. H. (2014). Will risk compensation accompany pre-exposure prophylaxis for HIV? The virtual mentor : VM, 16(11), 909-915. DOI:10.1001/virtualmentor.2014.16.11.stas1-1411
Bolton, R. (1992). AIDS and promiscuity: muddles in the models of HIV prevention. Medical Anthropology, 14(2-4), 145-223.
Bruan, A. (2017). 'Truvada Whores' and the Class Divide. Pacific Standard. Retrieved from https://psmag.com/social-justice/truvada-whores-and-the-aids-class-divide
Cairns, G. (2013). PrEP wars: debating pre-exposure prophylaxis in the gay community. NAM AIDSmap.
Calabrese, S. K., & Underhill, K. (2015). How stigma surrounding the use of HIV preexposure prophylaxis undermines prevention and pleasure: a call to destigmatize “truvada whores”. American Journal of Public Health, 105(10), 1960-1964. DOI: https://doi.org/10.2105/AJPH.2015.302816
Cassidy, (2013). Hivtester papirløse migranter. Sykepleien. https://sykepleien.no/sites/default/files/documents/forsknings/1152680.pdf
Christiansen, J. (2016). PrEP-behandling og det personlige ansvar.
Collins, L. C. (2021). Pre-exposure prophylaxis (PrEP) and ‘risk’in the news. Journal of risk research, 1-16. DOI: https://doi.org/10.1080/13669877.2021.1894470
Crimp, D. (1987). How to have promiscuity in an epidemic. October, 43, 237-271.
Dean, T. (2015). Mediated intimacies: Raw sex, Truvada, and the biopolitics of chemoprophylaxis. Sexualities, 18(1-2), 224-246. DOI: https://doi.org/10.1177/1363460715569137
Dean, T. J. (2009). Unlimited intimacy: Reflections on the subculture of barebacking: University of Chicago Press.
Dembosky, A. (2016). From Maverick AIDS Activist To Porn Cop: The Man Behind Proposition 60. NPR. doi:https://www.npr.org/sections/health-shots/2016/11/02/500039336/from-maverick-aids-activist-to-porn-cop-the-man-behind-proposition-60
Derrida, J. (1976). Of Grammatology, trans. Gayatri Chakravorty Spivak. In: Baltimore: Johns Hopkins University Press.
Derrida, J. (2004). Dissemination: A&C Black.
Derrida, J. (2014a). Plato’s pharmacy. In Tragedy (pp. 338-360): Routledge.
Derrida, J. (2014b). Plato’s pharmacy: Routledge.
Derrida, J. (2016). Of grammatology: JHU Press.
Duran, D. (2012). Truvada whores. The Huffington Post, 12.
Gagnon, M. (2009). (Re) Thinking the Corporeality of HIV/AIDS in the Post-HAART Era: A Critical Perspective. Aporia, 1(3).
Gaspar, M., Salway, T., & Grace, D. (2021). Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation. Social Theory & Health, 1-17. DOI: 10.1080/09581596.2021.1970720
Gillis, J. R. (1997). Sexual Ecology: AIDS, and the Destiny of Gay Men. The Canadian Journal of Human Sexuality, 6(4), 335-338.
Gonzalez, O. R. (2019). HIV-Pre-Exposure Prophylaxis (PrEP),“The Truvada Whore,” and the New Gay Sexual Revolution. Raw: Prep, pedagogy, and the politics of barebacking, 47-70.
NIPH (2022). Årsrapport 2021 for hiv-infeksjon, gonoré og syfilis. Retrieved from https://www.fhi.no/globalassets/dokumenterfiler/trykksaker/gonore-syfilis-hiv-klamydia/arsoppgjor-2021-hiv-gonore-syfilis-siste.pdf
Herlinghaus, H. (2018). The Pharmakon: Concept Figure, Image of Transgression, Poetic Practice: Universitätsverlag Winter.
Holt, M. (2015). Configuring the users of new HIV-prevention technologies: the case of HIV pre-exposure prophylaxis. Culture, health & sexuality, 17(4), 428-439. DOI: https://doi.org/10.1080/13691058.2014.960003
Holt, M., Newman, C. E., Lancaster, K., Smith, A. K., Hughes, S., & Truong, H. H. M. (2019). HIV pre‐exposure prophylaxis and the ‘problems’ of reduced condom use and sexually transmitted infections in Australia: a critical analysis from an evidence‐making intervention perspective. Sociology of health & illness, 41(8), 1535-1548. DOI: https://doi.org/10.1111/1467-9566.12967
NKSOI (2015). PrEP – veileder for helsepersonell. Retrieved from https://oslo-universitetssykehus.no/seksjon/nasjonal-kompetansetjeneste-for-seksuelt-overforte-infeksjoner/Documents/58958_PrEP_Veileder_Lege_brosjyre_A5_k1.22.06.18.pdf
Jensen, F (2016). Politisk støtte til nyt skjold mod HIV. Berlingske.
Jones, C., Young, I., & Boydell, N. (2020). The people vs the NHS: Biosexual citizenship and hope in stories of PrEP activism. Somatechnics, 10(2), 172-194. DOI: https://doi.org/10.3366/soma.2020.0312
Juzwiak, R. (2014). What Is Safe Sex? The Raw and Uncomfortable Truth About Truvada. Gawker. Retrieved from https://www.gawker.com/what-is-safe-sex-the-raw-and-uncomfortable-truth-about-1535583252
Karris, M. Y., Beekmann, S. E., Mehta, S. R., Anderson, C. M., & Polgreen, P. M. (2014). Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada. Clinical Infectious Diseases, 58(5), 704-712. DOI: https://doi.org/10.1093/cid/cit796
Kenworthy, N., Thomann, M., & Parker, R. (2018). From a global crisis to the ‘end of AIDS’: New epidemics of signification. Global Public Health, 13(8), 960-971. DOI: https://doi.org/10.1080/17441692.2017.1365373
Kippax, S., & Stephenson, N. (2016). Socialising the biomedical turn in HIV prevention: Anthem Press.
(2013).
Policy notat: Papirløse innvandrere. Den Norske Legeforeningen. https://www.legeforeningen.no/contentassets/618b14a32a8340e8a9cf8d90af22fd0e/papirlose-innvandrere.pdf
The Norwegian Medical Association (2021). Faglige retningslinjer for oppfølging og behandling av hiv. Retrieved from https://www.legeforeningen.no/contentassets/c9b2a4d3790f49a283f6d909d7375b45/hivretningslinjer2021.pdf
Linnestad, L. (2019). Resistens på blå resept? Klassekampen. Retrieved from https://klassekampen.no/utgave/2019-11-16/resistens-pa-bla-resept
Liu, A., Colfax, G., Cohen, S., Bacon, O., Kolber, M., Amico, K., . . . Buchbinder, S. (2012). The spectrum of engagement in HIV prevention: proposal for a PrEP cascade. Paper presented at the 7th International conference on HIV treatment and prevention adherence.
Mansø, L. (2019). Mænd får behandling med 'hiv p-pille' til 25.000 kroner om året. DR. Retrieved from https://www.dr.dk/nyheder/politik/maend-faar-behandling-med-hiv-p-pille-til-25000-kroner-om-aaret
Marent, B., Henwood, F., Darking, M., & Consortium, E. (2018). Ambivalence in digital health: Co-designing an mHealth platform for HIV care. Social science & medicine, 215, 133-141. DOI: https://doi.org/10.1016/j.socscimed.2018.09.003
McClelland, A. (2019). Unprepared. Is PrEP, the drug that prevents HIV, bringing revolution or regression? Maison Neuve. Retrieved from https://maisonneuve.org/article/2019/03/20/unprepared/
McDowell, A. (2017). Mohit's Pharmakon: symptom, rotational bodies, and pharmaceuticals in rural Rajasthan. Medical Anthropology Quarterly, 31(3), 332-348. DOI: https://doi.org/10.1111/maq.12345
Meyers, T. (2014). Promise and deceit: Pharmakos, drug replacement therapy, and the perils of experience. Culture, Medicine, and Psychiatry, 38(2), 182-196. DOI: https://doi.org/10.1007/s11013-014-9376-9
Montaño, M. A., Dombrowski, J. C., Dasgupta, S., Golden, M. R., Duerr, A., Manhart, L. E., . . . Khosropour, C. M. (2019). Changes in sexual behavior and STI diagnoses among MSM initiating PrEP in a clinic setting. AIDS and Behavior, 23(2), 548-555. DOI: https://doi.org/10.1007/s10461-018-2252-9
Montess, M. (2020). Demedicalizing the Ethics of PrEP as HIV Prevention: The Social Effects on MSM. Public Health Ethics, 13(3), 288-299.
Mowlabocus, S. (2020). ‘What a skewed sense of values’: Discussing PreP in the British press. Sexualities, 23(8), 1343-1361. DOI: https://doi.org/10.1177/1363460719872726
Nguyen, V.-K. (2009). Therapeutic evangelism—Confessional technologies, antiretrovirals and biospiritual transformation in the fight against AIDS in West Africa. In AIDS and religious practice in Africa (pp. 359-378): Brill. DOI: https://doi.org/10.1163/ej.9789004164000.i-410.117
Nguyen, V.-K., O’malley, J., & Pirkle, C. M. (2011). Remedicalizing an epidemic: from HIV treatment as prevention to HIV treatment is prevention. Aids, 25(11), 1435. DOI: https://doi.org/10.1097/QAD.0b013e3283483697
Orne, J., & Gall, J. (2019). Converting, monitoring, and policing PrEP citizenship: Biosexual citizenship and the PrEP surveillance regime. Surveillance & Society, 17(5), 641-661. DOI: https://doi.org/10.24908/ss.v17i5.12945
Patton, C. (1985). Sex and germs: The politics of AIDS. Black Rose Books.
Pederesen, F. S. (2016). Dyrt HIV-skjold for bøsser på vej til Danmark. Berlingske. Retrieved from https://www.berlingske.dk/samfund/dyrt-hiv-skjold-for-boesser-paa-vej-til-danmark
Persson, A. (2004). Incorporating pharmakon: HIV, medicine, and body shape change. Body & Society, 10(4), 45-67. DOI: https://doi.org/10.1177/1357034X04047855
Persson, A. (2013). Non/infectious corporealities: tensions in the biomedical era of ‘HIV normalisation’. Sociology of health & illness, 35(7), 1065-1079. DOI: https://doi.org/10.1111/1467-9566.12023
Persson, A., Newman, C. E., & Ellard, J. (2017). Breaking binaries? Biomedicine and serostatus borderlands among couples with mixed HIV status. Medical anthropology, 36(8), 699-713. DOI: https://doi.org/10.1080/01459740.2017.1298594
Piška, N. (2017). Aristotle’s Pharmacy. Pólemos, 11(1), 5-21. DOI: https://doi.org/10.1515/pol-2017-0002
Plato, H. (1961). Phaedrus. In The Collected Dialogues of Plato (pp. 475-525): Princeton University Press.
Preciado, P. B. (2013). Testo junkie: Sex, drugs, and biopolitics in the pharmacopornographic era: The Feminist Press at CUNY.
Quaife, M., MacGregor, L., Ong, J. J., Gafos, M., Torres-Rueda, S., Grant, H., . . . Vickerman, P. (2020). Risk compensation and STI incidence in PrEP programmes. The lancet HIV, 7(4), e222-e223. DOI: https://doi.org/10.1016/S2352-3018(19)30333-9
Race, K. (2009). Pleasure consuming medicine: The queer politics of drugs: Duke University Press.
Race, K. (2016). Reluctant objects: sexual pleasure as a problem for HIV biomedical prevention. GLQ: A journal of Lesbian and Gay Studies, 22(1), 1-31. DOI: https://doi.org/10.1215/10642684-3315217
Rinella, M. A. (2010). Pharmakon: Plato, drug culture, and identity in ancient Athens: Lexington Books.
Rojas Castro, D., Delabre, R. M., & Molina, J. M. (2019). Give PrEP a chance: moving on from the “risk compensation” concept. Journal of the International AIDS society, 22, e25351. DOI: https://doi.org/10.1002/jia2.25351
Sanden, K. (2020). PrEP – Ny sexuell revolution med förhinder. Ottar. Retrieved from https://www.ottar.se/prep-ny-sexuell-revolution-med-f-rhinder/
Slagstad, K. (2016). Freedom in a pill? Tidsskrift for Den norske legeforening.
Smith, A. K., Newman, C. E., Haire, B., & Holt, M. (2021). Clinician imaginaries of HIV PrEP users in and beyond the gay community in Australia. Culture, Health & Sexuality, 1-15. DOI: https://doi.org/10.1080/13691058.2021.1957152
Spencer, S. (2016). NHS fights back against ruling forcing it to hand out 'promiscuity pill' that prevents HIV as the £20m cost will hit its ability to treat cancer and give limbs to amputees The Daily Mail. Retrieved from https://www.dailymail.co.uk/news/article-3720706/What-skewed-sense-values-NHS-told-5-000-year-lifestyle-drug-prevent-HIV-vital-cataract-surgery-rationed.html
Stensbak, H. (2019). Når vi tvinges til å velge mellom hiv og migrene. Aftenposten. Retrieved from https://www.aftenposten.no/meninger/debatt/i/AdB9vz/naar-vi-tvinges-til-aa-velge-mellom-hiv-og-migrene-helle-stensbak
Stiegler, B. (2013). What makes life worth living: On pharmacology: John Wiley & Sons.
The Lancet HIV (2015). PrEP: why are we waiting? The lancet HIV, 2(10), e401. DOI::10.1016/S2352-3018(15)00185-X
Tetteh, R. A., Yankey, B. A., Nartey, E. T., Lartey, M., Leufkens, H. G., & Dodoo, A. N. (2017). Pre-exposure prophylaxis for HIV prevention: safety concerns. Drug safety, 40(4), 273-283. DOI: https://doi.org/10.1007/s40264-017-0505-6
Treichler, P. A. (1999). How to have theory in an epidemic: Cultural chronicles of AIDS: Duke University Press.
UNAIDS. (2020). 2020 Global AIDS Update — Seizing the moment — Tackling entrenched inequalities to end epidemics. Retrieved from https://www.unaids.org/en/resources/documents/2020/global-aids-report
Weinmeyer, R. (2014). Truvada: No Substitute for Responsible Sex. The Hastings Center. Retrieved from https://www.thehastingscenter.org/truvada-no-substitute-for-responsible-sex/
Weinstein, M. (2015). The War Against Prevention. Business Wire. Retrieved from https://www.businesswire.com/news/home/20150616006589/en/CORRECTING%C2%A0and-REPLACING%C2%A0GRAPHIC-AHF-President-Calls-Attention-to-%E2%80%9CThe-War-Against-Prevention%E2%80%9D-in-New-Editorial-Ad-Campaign
Downloads
Publiceret
Citation/Eksport
Nummer
Sektion
Licens
Copyright (c) 2023 Tony Sandset
Dette værk er under følgende licens Creative Commons Navngivelse –Ikke-kommerciel (by-nc).
Udgivelser i Kvinder, Køn og Forskning er beskyttet under Creative Commons License: CC Attribution-NonCommercial 4.0
